Oral appliances in the treatment of oromandibular dystonia: a systematic review

Meyer, Micheline De; Vereecke, Lisa; Bottenberg, Peter; Jacquet, Wolfgang; Sims, Anthony B.; Santens, Patrick

doi:10.1007/s13760-020-01404-4

Cited by 11 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The treatment of OMD must be multimodal and highly individualized, and the methods include pharmacological [4,82,84], BoNT [14][15][16][17][18][19][20][21][22][23][24][25]75,[144][145][146][147][148][149][150][151][152][153][154][155], muscle afferent block [73,156,157], occlusal splint [158,159], and surgical therapies (coronoidotomy) [160][161][162]. Due to the number of muscle spindles, muscle afferent block therapy is more effective for jaw closing muscles than for jaw opening muscles [73,156].…”

Section: Omdmentioning

confidence: 99%

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Yoshida

2022

Toxins

View full text Add to dashboard Cite

Various movement disorders, such as oromandibular dystonia, oral dyskinesia, bruxism, functional (psychogenic) movement disorder, and tremors, exist in the stomatognathic system. Most patients experiencing involuntary movements due to these disorders visit dentists or oral surgeons, who may be the first healthcare providers. However, differential diagnoses require neurological and dental knowledge. This study aimed to review scientific advances in botulinum toxin therapy for these conditions. The results indicated that botulinum toxin injection is effective and safe, with few side effects in most cases when properly administered by an experienced clinician. The diagnosis and treatment of movement disorders in the stomatognathic system require both neurological and dental or oral surgical knowledge and skills, and well-designed multicenter trials with a multidisciplinary team approach must be necessary to ensure accurate diagnosis and proper treatment.

show abstract

Section: Omdmentioning

confidence: 99%

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Yoshida

2022

Toxins

View full text Add to dashboard Cite

show abstract

“…Oral medication therapies are further limited by systemic side effects which are not usually seen with BoNT therapy (107). For oral medication in OMD, the recent system review pointed out that no definitive conclusions can be drawn about the type of patients that may benefit, nor about the preferred type or mode of the appliance (115).…”

Section: Oral Medicationsmentioning

confidence: 99%

Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update

Liang-jun

et al. 2021

Front. Neurol.

View full text Add to dashboard Cite

Meige syndrome (MS) is cranial dystonia characterized by the combination of upper and lower cranial involvement and including binocular eyelid spasms (blepharospasm; BSP) and involuntary movements of the jaw muscles (oromandibular dystonia; OMD). The etiology and pathogenesis of this disorder of the extrapyramidal system are not well-understood. Neurologic and ophthalmic examinations often reveal no abnormalities, making diagnosis difficult and often resulting in misdiagnosis. A small proportion of patients have a family history of the disease, but to date no causative genes have been identified to date and no cure is available, although botulinum toxin A therapy effectively mitigates the symptoms and deep brain stimulation is gaining increasing attention as a viable alternative treatment option. Here we review the history and progress of research on MS, BSP, and OMD, as well as the etiology, pathology, diagnosis, and treatment.

show abstract

“…Für die Behandlung von OMD wurde bisher über verschiedene Aufbissschienen berichtet [15,76]. Eine Aufbissschiene (▶Abb.…”

Section: Therapie Mit Aufbissschienenunclassified

Behandlungsstrategien bei oromandibulärer Dystonie

Yoshida

2021

Fortschr Neurol Psychiatr

View full text Add to dashboard Cite

ZusammenfassungEine oromandibuläre Dystonie ist charakterisiert durch unwillkürliche tonische oder klonische Spasmen der Kau- und / oder Zungenmuskulatur bzw. der Muskeln im stomatognathen System. Sie wird oft fälschlicherweise als kraniomandibuläre Dysfunktion oder psychiatrische Erkrankung diagnostiziert. Aufgrund der klinischen Bilder wird die oromandibuläre Dystonie in 6 Subtypen (Kieferschluss-, Kieferöffnungs-, Zungen-, Kieferdeviations-, Kieferprotrusions-, und Lippendystonie) eingeteilt. Es gibt verschiedene Behandlungsmethoden, z. B. Injektion von Botulinum-Toxin, Muskelafferenzblockierung (Injektionen von Lidocain und Äthanol in die Kau- oder Zungenmuskulatur zur Blockierung der Afferenzen der Muskelspindeln), Aufbissschiene und chirurgische Eingriffe (Coronoidotomie). In vielen Fällen können aufgrund des Subtyps die Symptome durch eine Kombination dieser Methoden erfolgreich behandelt werden. In diesem Leitthema werden spezielle Therapieempfehlungen für jeden Subtyp beschrieben. Eine genaue Diagnose und Behandlung einer oromandibulären Dystonie erfordert umfassende Kenntnisse und Fähigkeiten sowohl in der Mund-, Kiefer- und Gesichtschirurgie als auch in der Neurologie. Daher ist die Zusammenarbeit zwischen diesen Abteilungen sehr wichtig.

show abstract

Oral appliances in the treatment of oromandibular dystonia: a systematic review

Cited by 11 publications

References 20 publications

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update

Behandlungsstrategien bei oromandibulärer Dystonie

Contact Info

Product

Resources

About